...
首页> 外文期刊>Journal of Animal Science >Pediocin A modulates intestinal microflora metabolism in swine in vitro intestinal fermentations
【24h】

Pediocin A modulates intestinal microflora metabolism in swine in vitro intestinal fermentations

机译:Pediocin A调节猪体外肠道发酵中的肠道菌群代谢

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to investigate in vitro the effects of pediocin A [a bacteriocin produced by lactic acid bacteria (LAB) Pediococcus pentosaceus FBB61] on microbial metabolism in the small and large intestine of pigs. Pediocin A was partially purified by ion exchange chromatography and added to an in vitro fermentation system. The intestinal inoculum was collected from pigs immediately after slaughter, diluted with a buffer, and dispensed into fermentation syringes and vessels of the 2 experimental groups: 1) Bac+ = cecal liquor + predigested diet + pediocin A (final concentration 160 activity units/mL); 2) Bac- = cecal liquor + predigested diet + partially purified supernatant of P. pentosaceus FBB61-2. Intestinal microbial growth was monitored using the cumulative gas production technique; the kinetics of fermentation, bacterial counts, VFA, ammonia, polyamines, and p-cresol production were analyzed. Pediocin A had almost no effects on small intestine fermentation parameters, whereas in the cecum pediocin A decreased gas production (-16%; P < 0.05), ammonia, and VFA production (-52 and -21%, respectively, after 24 h; P < 0.001) compared with the control group. Significant inhibition of clostridia and LAB occurred in cecal fermentations: the Bac+ group yielded a decreased number of clostridia and LAB in cecal fermentations (8.19 and 7.80 cfu/mL, respectively) compared with Bac- (9.32 and 8.95 cfu/mL, respectively; P < 0.001). The low clostridia counts in the pediocin-treated group may also explain the reduced concentration of the carcinogenic compound p-cresol (-88%; P < 0.01). Our results suggest that pediocin A could be an alternative to replace antibiotic growth promoters for the prophylaxis of enteric diseases and to improve production of farm animals.
机译:这项研究的目的是在体外研究pediocin A [一种由乳酸菌(LAB)戊糖小球菌FBB61产生的细菌素]对猪小肠和大肠微生物代谢的影响。 Pediocin A通过离子交换色谱法部分纯化,并添加到体外发酵系统中。屠宰后立即从猪中收集肠接种物,用缓冲液稀释,并分配到2个实验组的发酵注射器和容器中:1)Bac + =盲肠液+消化饮食+ pediocin A(终浓度为160活性单位/ mL) ; 2)Bac- =盲肠酒+预先消化的饮食+戊糖假单胞菌FBB61-2的部分纯化的上清液。使用累积气体生产技术监测肠道微生物的生长;分析了发酵的动力学,细菌数,VFA,氨,多胺和对甲酚的产生。 Pediocin A对小肠发酵参数几乎没有影响,而在盲肠中,pediocin A在24小时后产气量减少(-16%; P <0.05),氨气和VFA产生量分别减少(-52和-21%)。 P <0.001)与对照组相比。在盲肠发酵中对梭菌和乳酸菌有显着抑制作用:与Bac-(分别为9.32和8.95 cfu / mL)相比,Bac +组在盲肠发酵中梭菌和LAB的数量减少(分别为9.22和8.95 cfu / mL; P <0.001)。 pediocin治疗组的梭菌计数低也可以解释致癌化合物对甲酚浓度降低(-88%; P <0.01)。我们的结果表明,pediocin A可以替代抗生素生长促进剂以预防肠道疾病并提高农场动物的生产能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号